Language
English
Publication Date
12-9-2025
Journal
Nature Communications
DOI
10.1038/s41467-025-67328-w
PMID
41366257
PMCID
PMC12689812
PubMedCentral® Posted Date
12-9-2025
PubMedCentral® Full Text Version
Post-print
Abstract
The immunosuppressive tumour microenvironment (TME) remains a central barrier to effective immunotherapy in solid tumours. We present a gene-therapeutic strategy that enables localized remodelling of the TME via tumour-intrinsic cytokine expression. Central to this approach is CancerPAM, a multi-omics bioinformatics pipeline that identifies and ranks patient-specific, tumour-exclusive CRISPR-Cas9 knock-in sites with high specificity and integration efficiency. Using neuroblastoma as a model, CancerPAM analysis of tumour sequencing data identifies optimal knock-in sites for pro-inflammatory cytokines (CXCL10, CXCL11, IFNG), and CancerPAM rankings correlate strongly with target-site specificity and knock-in efficiency, validating its predictive performance. CRISPR-mediated CXCL10 knock-in enhances CAR T cell infiltration and antitumour efficacy in vitro and in vivo, including humanized CD34⁺ HuNOG mice, where CXCL10-expressing tumours show stronger immune infiltration and prolonged tumour control within a reconstituted human immune microenvironment. Our findings establish a framework for safe and effective CRISPR-based cytokine delivery, integrating localized TME remodelling with cellular immunotherapies to enhance CAR T cells and other treatments in immune-refractory solid tumours.
Keywords
Tumor Microenvironment, Humans, Animals, Gene Knock-In Techniques, Mice, CRISPR-Cas Systems, Immunotherapy, Adoptive, Genetic Therapy, Chemokine CXCL10, Cytokines, Cell Line, Tumor, Neuroblastoma, Receptors, Chimeric Antigen, T-Lymphocytes, Chemokine CXCL11, Neoplasms, Interferon-gamma, Precision Medicine, Clustered Regularly Interspaced Short Palindromic Repeats, Female, Cancer immunotherapy, Cancer microenvironment, Genome informatics, Gene therapy, Personalized medicine
Published Open-Access
yes
Recommended Citation
Launspach, Michael; Macos, Julia; Afzal, Shoaib; et al., "Personalized Crispr Knock-in Cytokine Gene Therapy to Remodel the Tumor Microenvironment and Enhance Car T Cell Therapy in Solid Tumors" (2025). Faculty, Staff and Students Publications. 8692.
https://digitalcommons.library.tmc.edu/baylor_docs/8692